ReviewCNS drugs2022

Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia.

Tanja Veselinović et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.